Author/Creator: Seddighzadeh, Ali - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Seddighzadeh, Ali

1. COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta‐1a and subcutaneous interferon beta‐1a over 2 weeks in healthy subjects. (29th May 2016)

Authors:: Hu, Xiao; Shang, Shulian; Nestorov, Ivan; Hasan, Jawad; Seddighzadeh, Ali; Dawson, Katherine; Sperling, Bjørn; Werneburg, Brian
Journal:: British journal of clinical pharmacology
Issue:: Volume 82:Number 2(2016:Aug.)
Page Start:: 380
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial. (July 2016)

Authors:: White, Joleen T.; Newsome, Scott D.; Kieseier, Bernd C.; Bermel, Robert A.; Cui, Yue; Seddighzadeh, Ali; Hung, Serena; Crossman, Mary; Subramanyam, Meena
Journal:: Therapeutic advances in neurological disorders
Issue:: Volume 9:Number 4(2016:Jul.)
Page Start:: 239
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE. (July 2015)

Authors:: Kieseier, Bernd C; Arnold, Douglas L; Balcer, Laura J; Boyko, Alexey A; Pelletier, Jean; Liu, Shifang; Zhu, Ying; Seddighzadeh, Ali; Hung, Serena; Deykin, Aaron; Sheikh, Sarah I; Calabresi, Peter A
Journal:: Multiple sclerosis
Issue:: Volume 21:Number 8(2015)
Page Start:: 1025
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta‐1a in subjects with normal or impaired renal function. (23rd September 2014)

Authors:: Hu, Xiao; Seddighzadeh, Ali; Stecher, Scott; Zhu, Ying; Goyal, Jaya; Matson, Mark; Marbury, Thomas; Smith, William; Nestorov, Ivan; Hung, Serena
Journal:: Journal of clinical pharmacology
Issue:: Volume 55:Number 2(2015:Feb.)
Page Start:: 179
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Population‐Based Pharmacokinetic and Exposure‐Efficacy Analyses of Peginterferon Beta‐1a in Patients With Relapsing Multiple Sclerosis. (10th April 2017)

Authors:: Hu, Xiao; Hang, Yaming; Cui, Yue; Zhang, Jie; Liu, Shifang; Seddighzadeh, Ali; Deykin, Aaron; Nestorov, Ivan
Journal:: Journal of clinical pharmacology
Issue:: Volume 57:Number 8(2017)
Page Start:: 1005
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study. (November 2014)

Authors:: Seddighzadeh, Ali; Hung, Serena; Selmaj, Krzysztof; Cui, Yue; Liu, Shifang; Sperling, Bjoern; Calabresi, Peter A
Journal:: Expert opinion on drug delivery
Issue:: Volume 11:Number 11(2014:Nov.)
Page Start:: 1713
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗